Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Endometrial Mixed Cell Adenocarcinoma

Clinical trial condition

Refractory Endometrial Mixed Cell Adenocarcinoma

Explore clinical trials studying Refractory Endometrial Mixed Cell Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory Endometrial Mixed Cell Adenocarcinoma trial results

Completed

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

NCT04719273

Conditions: Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Jefferson Abington Hospital Abington, Pennsylvania, United States

Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details